For immunochemical detection of FcγRIIIa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

FcγRIIIa/CD16a Polyclonal Antibody

Item No. 38098

Technical Information
Synonyms
  • FCG3
  • FCGR3A
  • FCR-10
  • FCRIIIa
  • FGR3A
Immunogen
Recombinant human CD16a
50, 100, or 200 µl of protein A-affinity purified polyclonal antibody
Storage Buffer
0.2 μm filtered solution in PBS
Host
Rabbit
Isotype
IgG
Applications
ELISA, IHC-P
Cross Reactivity
(+) FcγRIIIa
Species Reactivity
(+) Human(+) Cynomolgus monkey
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Fc γ receptor IIIa (FcγRIIIa), also known as CD16a, is an activating receptor for IgG with roles in antibody-dependent cell cytotoxicity (ADCC).1,2 It is expressed primarily in natural killer (NK) cells, but also in macrophages and non-classical monocytes.2,3 FcγRIIIa is composed of an extracellular domain which contains five N-glycosylation sites, a transmembrane helix, and a cytoplasmic tail.2 Upon binding of IgG, FcγRIIIa engages one of two signaling chains, CD3ζ or FcεRIγ, which is phosphorylated by the Src family kinase LCK and induces intracellular signaling and neutrophil activation.1 FcγRIIIa signaling is positively correlated with disease progression and pathogenic lung inflammation in patients with COVID-19.3 Mutations in FCGR3A, the gene encoding FcγRIIIa, are positively correlated with increased risk of colorectal carcinoma.4 Cayman’s FcγRIIIa/CD16a Polyclonal Antibody can be used for ELISA and immunohistochemistry-paraffin (IHC-P) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Coënon, L., and Villalba, M. From CD16a biology to antibody-dependent cell-mediated cytotoxicity improvement. Front. Immunol. 13, 913215 (2022).

    2. Patel, K.R., Benavente, M.C.R., Lorenz, W.W., et alFc γ receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells. The Journal of Biological Chemisty 296, 100183 (2021).

    3. Gonzalez, J.C., Chakraborty, S., Thulin, N.K., et alHeterogeneity in IgG-CD16 signaling in infectious disease outcomes. Immunol. Rev. 309(1), 64-74 (2022).

    4. Canossi, A., Aureli, A., Del Beato, T., et alRole of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. J. Transl. Med. 14(1), 239 (2016).